Skip to contentP
Pulse Biosciences, Inc.
P
PLSEPulse Biosciences, Inc. Q1 2022 · 10-Q
Revenue$444.00K$444.00Kno prior Q1 2021 on file Net Income-$17.27M-$17.27MN/M vs Q1 2021 EPS Diluted-$0.58-$0.58N/M vs Q1 2021 Operating Income-$17,273,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
Free Cash Flowderived-$15,873,000N/M Margins · derivedOperating margin-3890.3%
Net margin-3890.3%
ended Mar 31, 2022 · filed May 11, 2022 · 41 d after period end